Top Authors

• Most frequent coverage on ABII

• 
  ChinaBio Today (353 followers)

  • Spotlight on China Biomedical Investment (Sun, Jul 20)
  • Abraxis Receives China Approval for Cancer Drug (Wed, Jul 16)

  More by ChinaBio Today on ABII »
• 
  Mike Havrilla (1965 followers)

  • FDA Calendar Updates: BioMarin, OSI, Roche, Abraxis, Johnson & Johnson (Tue, Jul 14)

  More by Mike Havrilla on ABII »
• 
  Market Folly (4536 followers)

  • A Look at D.E. Shaw's Q408 Holdings: Just for Fun (Wed, Apr 22)

  More by Market Folly on ABII »

• Most followed authors on ABII

• 
  Market Folly (4536 followers)

  • A Look at D.E. Shaw's Q408 Holdings: Just for Fun (Wed, Apr 22)

  More by Market Folly on ABII »
• 
  Mike Havrilla (1965 followers)

  • FDA Calendar Updates: BioMarin, OSI, Roche, Abraxis, Johnson & Johnson (Tue, Jul 14)

  More by Mike Havrilla on ABII »
• 
  ChinaBio Today (353 followers)

  • Spotlight on China Biomedical Investment (Sun, Jul 20)
  • Abraxis Receives China Approval for Cancer Drug (Wed, Jul 16)

  More by ChinaBio Today on ABII »

• Newest authors on ABII

• 
  Mark Cifra (30 followers)

  • Who Will Buy Spectrum Pharmacueticals? (Thu, Aug 6)

  More by Mark Cifra on ABII »
• 
  Market Folly (4536 followers)

  • A Look at D.E. Shaw's Q408 Holdings: Just for Fun (Wed, Apr 22)

  More by Market Folly on ABII »
• 
  ChinaBio Today (353 followers)

  • Spotlight on China Biomedical Investment (Sun, Jul 20)
  • Abraxis Receives China Approval for Cancer Drug (Wed, Jul 16)

  More by ChinaBio Today on ABII »

• Most commented on ABII

• 
  Market Folly (4536 followers)

  • A Look at D.E. Shaw's Q408 Holdings: Just for Fun (Wed, Apr 22)

  More by Market Folly on ABII »
• 
  Mark Cifra (30 followers)

  • Who Will Buy Spectrum Pharmacueticals? (Thu, Aug 6)

  More by Mark Cifra on ABII »